How does gene therapy work? Who might benefit from it? What research is going on into using gene therapy to treat Parkinson’s disease? To respond to community questions about gene therapy, we’re resharing audio from a popular Third Thursdays Webinar on the topic. Tune in to listen to our expert panelists discuss the potential of gene therapies for Parkinson’s disease and the state of the research.
If you’d rather listen on the go, subscribe to The Michael J. Fox Foundations Parkinson’s Podcast on iTunes or your preferred podcast app. If you enjoyed what you heard, share it with a friend or leave a review! It helps listeners like you find and support our mission.
In this episode, host Maggie Kuhl, head of patient engagement at The Michael J. Fox Foundation (MJFF), speaks with:
- Christine Klein, MD, professor of neurology and neurogenetics, University of Lübeck, Germany
- Bradford Casey, PhD, senior associate director, research programs, MJFF
- Pola Sussman, a person with Parkinson’s, and her husband, Rich Sussman, who have joined multiple studies and considered a trial of Parkinson’s gene therapy
View a transcript of this podcast.
Whether you have Parkinson’s or not, you can help move research forward. Join the study that’s changing everything.